National Health Investors (NHI) furnishes new investor update and presentation

Rhea-AI Filing Summary

National Health Investors, Inc. furnished an updated investor presentation and a related press release on November 6, 2025. The materials, titled “NHI Issues Investor Update” and “National Health Investors Investor Update,” provide information for investors and are also available on the company’s website.

The company specifies that these materials are provided under Regulation FD and are furnished, not filed, meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other securities law filings unless specifically referenced.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 11/06/2025 - 04:29 PM Learn about SEC filing dates

FAQ

What did National Health Investors (NHI) disclose in this 8-K?

National Health Investors, Inc. disclosed that it furnished an investor presentation and an accompanying press release dated November 6, 2025, providing an investor update.

Which exhibits are included with NHI's November 6, 2025 investor update?

The filing lists Exhibit 99.1 as the press release titled “NHI Issues Investor Update” and Exhibit 99.2 as the presentation titled “National Health Investors Investor Update,” both dated November 6, 2025.

Are NHI's investor update materials considered filed with the SEC?

No. NHI states that the information in Item 7.01, including Exhibits 99.1 and 99.2, is furnished, not filed, and therefore is not subject to Section 18 liability and is not incorporated into other filings unless expressly referenced.

Where can investors access NHI's November 6, 2025 investor update?

The company notes that the investor presentation is also available on its website at www.nhireit.com, in addition to being furnished as exhibits to this report.

Who signed National Health Investors' November 6, 2025 8-K?

The report was signed on behalf of National Health Investors, Inc. by John L. Spaid, who is identified as the Principal Financial Officer, dated November 6, 2025.

0000877860FALSE00008778602025-11-062025-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Reported): November 6, 2025

National Health Investors, Inc.

(Exact name of registrant as specified in its charter)

Maryland

001-10822

62-1470956

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

222 Robert Rose Drive,

Murfreesboro, TN 37129

(Address of principal executive offices)

(615) 890-9100

(Registrant's telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year,

if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

NHI

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).             

Emerging growth company         ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

On November 6, 2025, the Company furnished an investor presentation, which is also contained on its website (www.nhireit.com), and issued a press release regarding the investor presentation. See Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.

The information contained in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information or exhibit be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

Exhibit Index
Number			Exhibit
99.1			Press Release Titled "NHI Issues Investor Update" dated November 6, 2025, in HTML format
99.2			Presentation Titled "National Health Investors Investor Update" dated November 6, 2025, in HTML format
104			Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

..

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NATIONAL HEALTH INVESTORS, INC.

By:    /s/ John L. Spaid

Name:    John L. Spaid

Title:    Principal Financial Officer

Date:    November 6, 2025